| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |